Dr. David Kandzari, MD
Claim this profilePiedmont Heart Institute
Studies Cardiovascular Disease
Studies Hypertension
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials David Kandzari, MD is currently running
Renal Denervation
for High Blood Pressure
This trial is studying the safety and effectiveness of a device called the Symplicity Spyral system, which helps lower blood pressure by calming overactive nerves in the kidneys. It includes patients who have already received this treatment. The Symplicity Spyral system is part of a series of treatments, with earlier versions showing significant blood pressure reductions in patients with resistant hypertension.
Recruiting1 award N/A1 criteria
Coronary Dilatation Catheter
for Heart Disease
A prospective, open label, multi-center, single arm, observational study designed to evaluate the acute safety and device performance of the Sapphire 3 0.85, 1.0 and 1.25mm diameter coronary dilatation catheter in predilatation of Chronic Total Occlusion (CTO) lesions during percutaneous coronary intervention. One hundred seventy (170) subjects will be enrolled with a target of one hundred fifty-three (153) evaluable subjects by the angiographic core laboratory at up to 15 clinical sites with the Sapphire 3 0.85, 1.0 and 1.25mm diameter PTCA dilatation catheter to pre-dilate CTO lesions in coronary arteries during their index procedure. All subjects will be screened according to the protocol inclusion and exclusion criteria and will be followed through study completion, which is defined as 24-hours post-procedure or hospital discharge, whichever comes first.
Recruiting1 award N/A5 criteria
More about David Kandzari, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Kandzari, MD has experience with
- Symplicity Spyral™
- Sapphire 3 Coronary Dilatation Catheter
- Dehydrated Alcohol
- Peregrine System Kit
- Sham Procedure
- Symplicity Spyral™ Multi-electrode Renal Denervation System
Breakdown of trials David Kandzari, MD has run
Cardiovascular Disease
Hypertension
High Blood Pressure
Vascular Disease
Coronary Heart Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Kandzari, MD specialize in?
David Kandzari, MD focuses on Cardiovascular Disease and Hypertension. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is David Kandzari, MD currently recruiting for clinical trials?
Yes, David Kandzari, MD is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that David Kandzari, MD has studied deeply?
Yes, David Kandzari, MD has studied treatments such as Symplicity Spyral™, Sapphire 3 Coronary Dilatation Catheter, Dehydrated alcohol.
What is the best way to schedule an appointment with David Kandzari, MD?
Apply for one of the trials that David Kandzari, MD is conducting.
What is the office address of David Kandzari, MD?
The office of David Kandzari, MD is located at: Piedmont Heart Institute, Atlanta, Georgia 30309 United States. This is the address for their practice at the Piedmont Heart Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.